MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 13.08.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
655 K |
Marktkapitalisierung |
$ 826 K |
EBITDA (LTM) |
$ -32 M |
P/E (LTM) |
- |
P/S (LTM) |
0.76 |
EPS (LTM) |
-8.97 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Alterity Therapeutics Limited
ATHE
|
$ 4.55 | -0.66 % | $ 10.9 B | Nasdaq Capital Market |  Australia |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Compugen Ltd.
CGEN
|
$ 2.59 | -5.31 % | $ 242 M | Nasdaq Global Market,SPB |  Israel |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Aptorum Group Limited
APM
|
$ 0.91 | 3.25 % | $ 6.69 M | Nasdaq Global Select Market | China |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | France |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 22.57 | -0.44 % | $ 3.74 B | Nasdaq Global Select Market,SPB | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Evogene Ltd.
EVGN
|
$ 0.78 | -0.66 % | $ 27.9 M | Nasdaq Global Market | Israel |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Fennec Pharmaceuticals
FENC
|
$ 6.33 | -5.52 % | $ 181 M | Nasdaq Capital Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Galapagos NV
GLPG
|
$ 27.94 | -1.69 % | $ 2.69 B | Nasdaq Global Select Market |  Belgium |
 |
Genmab A/S
GMAB
|
$ 26.19 | -2.24 % | $ 16 B | Nasdaq Global Select Market |  Danmark |
 |
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market |  Canada |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market | Israel |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | USA |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
BioNTech SE
BNTX
|
$ 100.7 | -1.33 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Brainstorm Cell Therapeutics
BCLI
|
- | -2.5 % | $ 5.88 M | Nasdaq Capital Market | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
 |
Innoviva
INVA
|
$ 23.2 | -2.08 % | $ 1.56 B | Nasdaq Global Select Market | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.45 | 3.57 % | $ 235 M | Nasdaq Global Select Market | France |
 |
Inventiva S.A.
IVA
|
$ 4.93 | -1.5 % | $ 138 M | Nasdaq Global Market | France |
 |
Aquestive Therapeutics
AQST
|
$ 4.06 | -0.73 % | $ 434 M | Nasdaq Global Market | USA |
 |
Jaguar Health
JAGX
|
$ 0.23 | -5.44 % | $ 536 K | Nasdaq Capital Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 22.63 | -2.86 % | $ 2.88 B | Nasdaq Global Select Market,SPB | USA |
 |
KalVista Pharmaceuticals
KALV
|
$ 26.73 | 38.9 % | $ 1.44 B | Nasdaq Global Select Market | Britain |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.42 | -4.39 % | $ 378 M | Nasdaq Global Select Market | Britain |
 |
Kamada Ltd.
KMDA
|
$ 8.14 | -0.09 % | $ 260 M | Nasdaq Global Select Market | Israel |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
AstraZeneca PLC
AZN
|
- | - | $ 96.9 B | Nasdaq Global Select Market | Britain |
 |
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 2.95 | 1.37 % | $ 4.86 M | NYSE American | Israel |